Table 2 Effect of BV and BPF treatment on acrylamide and chips administration on the plasma GOT (U/ml), GPT (U/ml), and albumin (g/dl) for 60 day

94.9 ± 3.72

160.16 ± 3.29^a**

178.4 ± 15.50^a**

99.6 ± 9.74^b**^{, c}*

103.8 ± 9.14^b**^c*

110.9 ± 6.25^b**^{, c}*

103.5 ± 10.39^b**^{, c}*

103.8 ± 6.20^b**^{, c}*

106.6 ± 8.80^b**^{, c}*

% of change

1

–

+ 68.76

+ 87.98

+ 4.95

+ 9.37

+ 16.85

+ 9.06

+ 9.37

+ 12.32

2

–

–

+ 11.38

− 37.81

− 35.18

− 30.75

− 35.37

− 35.18

− 33.44

3

–

–

–

− 44.17

− 41.81

− 37.83

− 41.98

− 41.81

− 40.24

110.4 ± 6.73

178.6 ± 11.41^a**

143.8 ± 4.35^a*^{, b}*

113 ± 7.43^b*^{, c}*

122.8 ± 4.58^b*^{, c}*

97.8 ± 8.97^b**^{, c}*

125 ± 4.53^b*^{, c}*

116.2 ± 7.61^b*^{, c}*

114.6 ± 7.11^b*^{, c}*

% of change

1

–

+ 61.7

+ 30.25

+ 2.35

+ 11.23

− 11.41

+ 13.22

+ 5.25

+ 3.80

2

–

–

− 19.48

− 36.73

− 31.24

− 45.24

− 30.01

−34.93

− 35.83

3

–

–

–

− 21.41

− 14.60

− 31.98

− 13.07

− 19.19

− 20.30

3.696 ± 0.22

2.586 ± 0.036^a*

2.968 ± 0.28

3.476 ± 0.09^b**

3.606 ± 0.19^b**

3.852 ± 0.11_b**^{, c}*

3.732 ± 0.138^b**^{, c}*

3.63 ± 0.21^b*

3.82 ± 0.17^b**^{, c}*

% of change

1

–

− 30.08

− 19.78

− 5.95

− 2.43

+ 4.33

+ 1.08

− 1.62

3.52

2

–

–

+ 14.77

+ 34.41

+ 39.44

+ 48.95

+ 44.31

+ 40.37

+ 47.71

3

–

–

–

+ 17.11

+ 21.49

+ 29.78

+ 25.74

+ 22.30

+ 28.70